References: |
1. Takes R P, Baatenburg de Jong R J, Wijffels K, et al.. Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer. Journal of Pathology. 194:298-302 (2001). 2. Tweddle D A, Malcolm A J, Cole M, et al.. p53 cellular localization and function in neuroblastoma. American Journal of Pathology. 158(6):2067-2077 (2001). 3. LeBrun D P, Kamel O W, Cleary M L, et al.. Follicular lymphomas of the gastrointestinal tract. Pathologic features in 31 cases and bcl-2 oncogenic pro- tein expression. American Journal of Pathology. 140:1327-1335 (1992). 4. Liu Y J, Mason D Y, Johnson G D, et al.. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. European Journal of Immunology. 21:1905-1910 (1991). 5.
Hockenbery D, Nunez G, Milliman C, et al.. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 348:334- 336 (1990). 6. Pezella F, Tse A G D, Cordell J L, et al.. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. 7. American Journal of Pathology. 137:225-232 (1990). 8. Tsujimoto Y and Croce C M. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proceedings of the National Academy of Science (USA). 83:5214-5218 (1986). |